Dietary Flaxseed Reduces Central Aortic Blood Pressure Without Cardiac Involvement but Through Changes in Plasma Oxylipins

Hypertension

Volumn 68, Issue 4, 2016, Pages 1031-1038

  Caligiuri, Stephanie P B ^a,b,c   Rodriguez Leyva, Delfin ^a,b,c   Aukema, Harold M ^a,c   Ravandi, Amir ^b,c   Weighell, Wendy ^d   Guzman, Randolph ^d   Pierce, Grant N ^a,b,c  

^a The Inst of Cardiovascular Sciences   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

^c Department of Physiology and Pathophysiology ^*  (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

central blood pressure; flaxseed; hypertension; nutrition; oxylipins; peripheral vascular disease; pulse wave analysis

Indexed keywords

HYDROXYICOSATETRAENOIC ACID; OXYLIPIN; PLACEBO; THROMBOXANE B2;

AGED; ANTIHYPERTENSIVE ACTIVITY; AORTA PRESSURE; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; HEART FUNCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; LINSEED; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE; TONOMETRY; ADULT; ANALYSIS OF VARIANCE; ARTERIAL PRESSURE; BLOOD; CARDIOVASCULAR DISEASES; CONTROLLED STUDY; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; FLAX; MALE; MIDDLE AGED; ODDS RATIO; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTERIAL PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FLAX; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; OXYLIPINS; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES; PULSE WAVE ANALYSIS; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 84981744981     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.07834     Document Type: Article

References (40)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252. doi: 10.1161/01.HYP.0000107251.49515.c2.
2. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-2260. doi: 10.1016/S0140-6736(12)61766-8.
3. Qureshi AI, Suri MF, Kirmani JF, Divani AA. Prevalence and trends of prehypertension and hypertension in United States: National Health and Nutrition Examination Surveys 1976 to 2000. Med Sci Monit. 2005;11:CR403-CR409.
4. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520. doi: 10.1001/jama.2013.284427.
5. Rodriguez-Leyva D, Weighell W, Edel AL, LaVallee R, Dibrov E, Pinneker R, Maddaford TG, Ramjiawan B, Aliani M, Guzman R, Pierce GN. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension. 2013;62:1081-1089. doi: 10.1161/HYPERTENSIONAHA.113.02094.
6. Caligiuri SP, Aukema HM, Ravandi A, Guzman R, Dibrov E, Pierce GN. Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an ?-linolenic acid-induced inhibition of soluble epoxide hydrolase. Hypertension. 2014;64:53-59. doi: 10.1161/HYPERTENSIONAHA.114.03179.
7. Elliott WJ, Ram CV. Calcium channel blockers. J Clin Hypertens (Greenwich). 2011;13:687-689. doi: 10.1111/j.1751-7176.2011.00513.x.
8. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M; CAFE Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFE Steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation. 2006;113:1213-1225. doi: 10.1161/CIRCULATIONAHA.105.595496.
9. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J. 2010;31:1865-1871. doi: 10.1093/eurheartj/ehq024.
10. Adji A, Hirata K, O'Rourke MF. Clinical use of indices determined noninvasively from the radial and carotid pressure waveforms. Blood Press Monit. 2006;11:215-221. doi: 10.1097/01.mbp.0000218001.50333.b7.
11. Leyva DR, Zahradka P, Ramjiawan B, Guzman R, Aliani M, Pierce GN. The effect of dietary flaxseed on improving symptoms of cardiovascular disease in patients with peripheral artery disease: rationale and design of the FLAX-PAD randomized controlled trial. Contemp Clin Trials. 2011;32:724-730. doi: 10.1016/j.cct.2011.05.005.
12. Aliani M, Ryland D, Pierce GN. Effect of flax addition on the flavor profile of muffins and snack bars. Food Res Int. 2011;44:2489-2496.
13. Aliani M, Ryland D, Pierce GN. Effect of flax addition on the flavor profile and acceptability of bagels. J Food Sci. 2012;77:S62-S70. doi: 10.1111/j.1750-3841.2011.02509.x.
14. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697-716. doi: 10.1161/01.CIR.0000154900.76284.F6.
15. Edel AL, Rodriguez-Leyva D, Maddaford TG, Caligiuri SP, Austria JA, Weighell W, Guzman R, Aliani M, Pierce GN. Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease. J Nutr. 2015;145:749-757. doi: 10.3945/jn.114.204594.
16. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
17. Brinton TJ, Cotter B, Kailasam MT, Brown DL, Chio SS, O'Connor DT, DeMaria AN. Development and validation of a noninvasive method to determine arterial pressure and vascular compliance. Am J Cardiol. 1997;80:323-330.
18. Markert M, Trautmann T, Groß M, Ege A, Mayer K, Guth B. Evaluation of a method to correct the contractility index LVdP/dt(max) for changes in heart rate. J Pharmacol Toxicol Methods. 2012;66:98-105. doi: 10.1016/j. vascn.2012.04.005.
19. Fantin F, Mattocks A, Bulpitt CJ, Banya W, Rajkumar C. Is augmentation index a good measure of vascular stiffness in the elderly? Age Ageing. 2007;36:43-48. doi: 10.1093/ageing/afl115.
20. Benetos A, Laurent S, Asmar RG, Lacolley P. Large artery stiffness in hypertension. J Hypertens Suppl. 1997;15:S89-S97.
21. Sohn SI, Kim CJ. Modulation of renin-angiotensin system and arterial stiffness: evidence from clinical trials. Curr Hypertens Rev. 2014;10:37-40.
22. Espinola-Klein C, Weisser G, Jagodzinski A, Savvidis S, Warnholtz A, Ostad MA, Gori T, Munzel T. Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial. Hypertension. 2011;58:148-154. doi: 10.1161/HYPERTENSIONAHA.110.169169.
23. Gebremedhin D, Ma YH, Imig JD, Harder DR, Roman RJ. Role of cytochrome P-450 in elevating renal vascular tone in spontaneously hypertensive rats. J Vasc Res. 1993;30:53-60.
24. Ma YH, Harder DR, Clark JE, Roman RJ. Effects of 12-HETE on isolated dog renal arcuate arteries. Am J Physiol. 1991;261(2 pt 2):H451-H456.
25. Sudhahar V, Shaw S, Imig JD. Epoxyeicosatrienoic acid analogs and vascular function. Curr Med Chem. 2010;17:1181-1190.
26. Falck JR, Krishna UM, Reddy YK, Kumar PS, Reddy KM, Hittner SB, Deeter C, Sharma KK, Gauthier KM, Campbell WB. Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation. Am J Physiol Heart Circ Physiol. 2003;284:H337-H349. doi: 10.1152/ajpheart.00831.2001.
27. McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med. 1998;338:273-277. doi: 10.1056/NEJM199801293380501.
28. Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science. 2002;296:539-541. doi: 10.1126/science.1068711.
29. Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem Rev. 2011;111:5922-5943. doi: 10.1021/cr100396c.
30. Puddu P, Puddu GM, Zaca F, Muscari A. Endothelial dysfunction in hypertension. Acta Cardiol. 2000;55:221-232. doi: 10.2143/AC.55.4.2005744.
31. Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, Touyz RM. Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can J Cardiol. 2015;31:631-641. doi: 10.1016/j.cjca.2015.02.008.
32. Harvey A, Montezano AC, Lopes RA, Rios F, Touyz RM. Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications. Can J Cardiol. 2016;32:659-668. doi: 10.1016/j. cjca.2016.02.070.
33. Reynaud D, Thickitt CP, Pace-Asciak CR. Facile preparation and structural determination of monohydroxy derivatives of docosahexaenoic acid (HDoHE) by alpha-tocopherol-directed autoxidation. Anal Biochem. 1993;214:165-170.
34. Caligiuri SP, Aukema HM, Ravandi A, Pierce GN. Elevated levels of pro-inflammatory oxylipins in older subjects are normalized by flaxseed consumption. Exp Gerontol. 2014;59:51-57. doi: 10.1016/j. exger.2014.04.005.
35. Carroll MA, Balazy M, Margiotta P, Huang DD, Falck JR, McGiff JC. Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides. Am J Physiol. 1996;271(4 pt 2):R863-R869.
36. Bednar MM, Gross CE, Balazy MK, Belosludtsev Y, Colella DT, Falck JR, Balazy M. 16-hydroxy-5,8,11,14-eicosatetraenoic acid, a new arachidonate metabolite in human polymorphonuclear leukocytes. Biochem Pharmacol. 2000;60:447-455.
37. Numabe A, Uehara Y, Hirawa N, Takada S, Yagi S. Effects of thiazide diuretic on vascular eicosanoid system of spontaneously hypertensive rats. J Hypertens. 1989;7:493-499.
38. Chen CH, Nevo E, Fetics B, Pak PH, Yin FC, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalized transfer function. Circulation. 1997;95:1827-1836.
39. Sharman JE, Lim R, Qasem AM, Coombes JS, Burgess MI, Franco J, Garrahy P, Wilkinson IB, Marwick TH. Validation of a generalized transfer function to noninvasively derive central blood pressure during exercise. Hypertension. 2006;47:1203-1208. doi: 10.1161/01.HYP.0000223013.60612.72.
40. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961-965.